Blue Owl Capital Corp

(a) Amounts are presented in accordance with Regulation S-X 17 CFR § 210.12-13C. Refer to “Note 7 — Derivative Instruments”for additional details on the Company’s interest rate swaps.

(a)Amounts are presented in accordance with Regulation S-X 17 CFR § 210.12-13B. Refer to “Note 7 — Derivative Instruments” for additional details on the Company’s foreign currency forward contracts.

(1)Certain portfolio company investments are subject to contractual restrictions on sales. Refer to footnote 30 for additional information on the Company’s restricted securities.

(2)The amortized cost represents the original cost adjusted for the amortization or accretion of premium or discount, as applicable, on debt investments using the effective interest method.

(3)Represents co-investment made with the Company’s affiliates in accordance with the terms of the exemptive relief that the Company received from the U.S. Securities and Exchange Commission. See “Note 3—Agreements and Related Party Transactions.”

(4)These investments were valued using unobservable inputs and are considered Level 3 investments.

(5)Investment measured at net asset value (“NAV”).

(6)Investment contains a fixed-rate structure.

(7)Unless otherwise indicated, loan contains a variable rate structure and may be subject to an interest rate floor. Variable rate loans bear interest at a rate that may be determined by reference to either the Secured Overnight Financing Rate (“SOFR” or “S,” which can include one-, three-, six- or twelve-month SOFR), Euro Interbank Offered Rate (“EURIBOR” or “E”, which can include one-, three- or six-month EURIBOR), Canadian Overnight Repo Rate Average (“CORRA” or “C”) (which can include one- or three-month CORRA), SONIA (“SONIA” or “SA”), Australian Bank Bill Swap Bid Rate (“BBSY” or “B”) (which can include one-, three-, or six-month BBSY) or an alternate base rate (which can include the Federal Funds Effective Rate or the Prime Rate), at the borrower’s option, and which reset periodically based on the terms of the loan agreement.

(8)The interest rate on these loans is subject to 1 month SOFR, which as of March 31, 2026 was 3.66%.

(9)The interest rate on these loans is subject to 3 month SOFR, which as of March 31, 2026 was 3.68%.

(10)The interest rate on these loans is subject to 6 month SOFR, which as of March 31, 2026 was 3.70%.

(11)Reserved.

(12)The interest rate on these loans is subject to Prime, which as of March 31, 2026 was 6.75%.

(13)The interest rate on this loan is subject to 1 month EURIBOR, which as of March 31, 2026 was 1.89%.

(14)The interest rate on this loan is subject to 3 month EURIBOR, which as of March 31, 2026 was 2.08%.

(15)The interest rate on this loan is subject to 6 month EURIBOR, which as of March 31, 2026 was 2.48%.

(16)Reserved.

(17)The interest rate on this loan is subject to 3 month BBSY, which as of March 31, 2026 was 4.31%.

(18)Reserved.

(19)The interest rate on this loan is subject to SONIA, which as of March 31, 2026 was 3.73%.

(20)Reserved.

(21)The interest rate on these loans is subject to 3 month CORRA, which as of March 31, 2026 was 2.29%.

(22)Position or portion thereof is a partially unfunded debt or equity commitment. See“Note 8—Commitments and Contingencies.”

*Fully funded

(23)The negative cost and fair value results from unamortized fees, which are capitalized to the investment cost of unfunded commitments.

(24)As defined in the Investment Company Act of 1940, as amended (the “1940 Act”), the Company is deemed to “control” a portfolio company if the Company owns more than 25% of the portfolio company's voting securities or has the power to exercise control over management or policies, including through a management agreement. As defined in the 1940 Act, the Company is an “affiliated person” of this portfolio company if the Company owns more than 5% or more of the portfolio company’s outstanding voting securities. Transactions related to the Company’s investments in non-controlled affiliates and controlled affiliates for the three months ended March 31, 2026, were as follows:

(a)Gross additions may include increases in the cost basis of investments resulting from new investments, amounts related to PIK interest capitalized and added to the principal balance of the respective loans, the accretion of discounts, the exchange of one or more existing investments for one or more new investments from a different category.

(b)Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments and sales, return of capital, the amortization of premiums and the exchange of one or more existing securities for one or more new securities.

(c)For further description of the Company's investment in Blue Owl Credit SLF LLC (“Credit SLF”), Blue Owl Leasing LLC (“Blue Owl Leasing”) and Owl-HP Finance see “Note 4 —Investments.”

(d)In connection with its investment in AAM Series 1.1 Rail and Domestic Intermodal Feeder, LLC and AAM Series 2.1 Aviation Feeder, LLC (collectively, “Amergin Assetco”) the Company made a minority investment in Amergin Asset Management, LLC, which has entered into a Servicing Agreement with Amergin Assetco.

(25)Unless otherwise indicated, the Company’s portfolio companies are pledged as collateral supporting the amounts outstanding under the Revolving Credit Facility, SPV Asset Facilities and CLOs. See “Note 5 —Debt.”

(26)Investment is not pledged as collateral for the credit facilities.

(27)As of March 31, 2026, the net estimated unrealized loss for U.S. federal income tax purposes was $113.1 million based on a tax cost basis of $15.46 billion. As of March 31, 2026, the estimated aggregate gross unrealized loss for U.S. federal income tax purposes was $563.3 million and the estimated aggregate gross unrealized gain for U.S. federal income tax purposes was $450.2 million.

(28)Loan was on non-accrual status as of March 31, 2026.

(29)Non-income producing.

(30)Securities acquired in transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”) and may be deemed to be “restricted securities” under the Securities Act. As of March 31, 2026, the aggregate fair value of these securities is $3.01 billion or 42.0% of the Company’s net assets. The acquisition dates of the restricted securities are as follows: